Poor air quality from wildfires may have an impact on mental health; a new executive order to lower prescription drug prices; Pfizer and BioNTech will expand the phase 3 trial of their COVID-19 vaccine.
As wildfires on the West Coast continue to cause record-breaking poor air quality in states such as California and Oregon, a San Francisco psychologist suggested a link with increased feelings of isolation and depression. Reported by ABC7 San Francisco, fires and the resulting smoke, as well as the coronavirus disease 2019 (COVID-19) have caused residents to stay inside to avoid risk of pollution and infection. Due to increased levels of pollution and the potential of seasonal affective disorder, a doctor of clinical psychology noted an increase in patients reporting headaches and signs of depression.
Yesterday, President Donald Trump signed a new executive order that he touts will lower prescription drug prices, but experts say that the move is unlikely to provide any immediate impact. Reported by NPR, the executive order repeals an executive order from 2 months ago that Trump announced but did not release to negotiate a better deal with drug companies. The new executive order will expand the drugs covered by Trump’s proposed “most favored nations” pricing scheme, which will include both Medicare Part B and Medicare Part D beneficiaries.
Reported by STAT, Pfizer and BioNTech announced they will expand the phase 3 trial of their COVID-19 vaccine by 50%, totaling to 44,000 participants. The move, which will increase data on safety and efficacy, will also promote a more diverse population that will include adolescents as young as 16, people with stable HIV, and people with hepatitis C or B. However, it was noted that the Pfizer, BioNTech vaccine could prove to be the most difficult of the experimental vaccines to distribute if proven effective as it must be kept at a temperature of –70 degrees celsius.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More